-+ 0.00%
-+ 0.00%
-+ 0.00%

REFILE-ALNYLAM PHARMACEUTICALS SHARES EXTEND LOSSES; LAST DOWN 18.5% PREMARKET (ADDS DROPPED WORD)

Reuters·10/29/2026 13:22:34